• Benign Prostatic Hyperplasia
  • Hormone Therapy
  • Genomic Testing
  • Next-Generation Imaging
  • UTUC
  • OAB and Incontinence
  • Genitourinary Cancers
  • Kidney Cancer
  • Men's Health
  • Pediatrics
  • Female Urology
  • Sexual Dysfunction
  • Kidney Stones
  • Urologic Surgery
  • Bladder Cancer
  • Benign Conditions
  • Prostate Cancer

Dr. Eastham describes updates to AUA guideline for clinically localized prostate cancer


The AUA partnered with ASTRO on the guideline and it was endorsed by the SUO.

James A. Eastham, MD, explains the updates that were made in the recently released 2022 clinical practice guideline for the management of clinically localized prostate cancer from the American Urological Association (AUA) and the American Society for Radiation Oncology (ASTRO). The guideline was shared during the 2022 AUA Annual Meeting and published in the Journal of Urology (doi: 10.1097/JU.0000000000002757). The guideline was also endorsed by the Society of Urologic Oncology (SUO).

Eastham is chair of guideline development panel and chief of Urology Services at Memorial Sloan Kettering Cancer Center.

Related Videos
Michael S. Cookson, MD, MMHC, FACS, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.